Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 369

1.

Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial.

Brignole M, Botto G, Mont L, Iacopino S, De Marchi G, Oddone D, Luzi M, Tolosana JM, Navazio A, Menozzi C.

Eur Heart J. 2011 Oct;32(19):2420-9. doi: 10.1093/eurheartj/ehr162. Epub 2011 May 23.

PMID:
21606084
2.

Predictors of clinical efficacy of 'Ablate and Pace' therapy in patients with permanent atrial fibrillation.

Brignole M, Botto GL, Mont L, Oddone D, Iacopino S, De Marchi G, Campoli M, Sebastiani V, Vincenti A, Garcia Medina D, Osca Asensi J, Mocini A, Grovale N, De Santo T, Menozzi C.

Heart. 2012 Feb;98(4):297-302. doi: 10.1136/heartjnl-2011-301069. Epub 2011 Nov 17.

PMID:
22095616
3.

Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: a meta-analysis.

Stavrakis S, Garabelli P, Reynolds DW.

Europace. 2012 Oct;14(10):1490-7. Epub 2012 Jun 13.

PMID:
22696519
4.

Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation.

Rönn F, Kesek M, Karp K, Henein M, Jensen SM.

Europace. 2011 Dec;13(12):1747-52. doi: 10.1093/europace/eur193. Epub 2011 Jun 28.

PMID:
21712261
5.

Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry).

Gasparini M, Leclercq C, Lunati M, Landolina M, Auricchio A, Santini M, Boriani G, Lamp B, Proclemer A, Curnis A, Klersy C, Leyva F.

JACC Heart Fail. 2013 Dec;1(6):500-7. doi: 10.1016/j.jchf.2013.06.003. Epub 2013 Oct 23.

7.

Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation.

Ferreira AM, Adragão P, Cavaco DM, Candeias R, Morgado FB, Santos KR, Santos E, Silva JA.

Europace. 2008 Jul;10(7):809-15. doi: 10.1093/europace/eun135. Epub 2008 May 28.

PMID:
18511438
8.

Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy.

Boriani G, Gasparini M, Landolina M, Lunati M, Proclemer A, Lonardi G, Iacopino S, Rahue W, Biffi M, DiStefano P, Grammatico A, Santini M; ClinicalService cardiac centres.

Eur J Heart Fail. 2011 Aug;13(8):868-76. doi: 10.1093/eurjhf/hfr046. Epub 2011 May 10.

9.

Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial.

Thébault C, Donal E, Meunier C, Gervais R, Gerritse B, Gold MR, Abraham WT, Linde C, Daubert JC; REVERSE study group.

Eur Heart J. 2012 Nov;33(21):2662-71. doi: 10.1093/eurheartj/ehr505. Epub 2012 Jan 26.

PMID:
22285578
10.

Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).

Healey JS, Hohnloser SH, Exner DV, Birnie DH, Parkash R, Connolly SJ, Krahn AD, Simpson CS, Thibault B, Basta M, Philippon F, Dorian P, Nair GM, Sivakumaran S, Yetisir E, Wells GA, Tang AS; RAFT Investigators.

Circ Heart Fail. 2012 Sep 1;5(5):566-70. Epub 2012 Aug 14.

11.

Complete atrioventricular block does not reduce long-term mortality in patients with permanent atrial fibrillation treated with cardiac resynchronization therapy.

Tolosana JM, Trucco E, Khatib M, Doltra A, Borras R, Castel MÁ, Berruezo A, Arbelo E, Sitges M, Matas M, Guasch E, Brugada J, Mont L.

Eur J Heart Fail. 2013 Dec;15(12):1412-8. doi: 10.1093/eurjhf/hft114. Epub 2013 Jul 11.

12.

Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.

Padeletti L, Muto C, Maounis T, Schuchert A, Bongiorni MG, Frank R, Vesterlund T, Brachmann J, Vicentini A, Jauvert G, Tadeo G, Gras D, Lisi F, Dello Russo A, Rey JL, Boulogne E, Ricciardi G; Management of Atrial fibrillation Suppression in AF-HF COmorbidity Therapy Study Group.

Am Heart J. 2008 Sep;156(3):520-6. doi: 10.1016/j.ahj.2008.04.013. Epub 2008 Jul 7.

PMID:
18760135
13.

Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing.

Leon AR, Greenberg JM, Kanuru N, Baker CM, Mera FV, Smith AL, Langberg JJ, DeLurgio DB.

J Am Coll Cardiol. 2002 Apr 17;39(8):1258-63.

14.

Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.

Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C; REVERSE (REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction) Study Group.

J Am Coll Cardiol. 2008 Dec 2;52(23):1834-43. doi: 10.1016/j.jacc.2008.08.027. Epub 2008 Nov 7.

15.

Preventing ventricular dysfunction in pacemaker patients without advanced heart failure: results from a multicentre international randomized trial (PREVENT-HF).

Stockburger M, Gómez-Doblas JJ, Lamas G, Alzueta J, Fernández-Lozano I, Cobo E, Wiegand U, Concha JF, Navarro X, Navarro-López F, de Teresa E.

Eur J Heart Fail. 2011 Jun;13(6):633-41. doi: 10.1093/eurjhf/hfr041.

16.

Adverse effects of long-term right ventricular apical pacing and identification of patients at risk of atrial fibrillation and heart failure.

De Sisti A, Márquez MF, Tonet J, Bonny A, Frank R, Hidden-Lucet F.

Pacing Clin Electrophysiol. 2012 Aug;35(8):1035-43. doi: 10.1111/j.1540-8159.2012.03371.x. Epub 2012 Mar 27. Review.

PMID:
22452247
17.

Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study).

Doshi RN, Daoud EG, Fellows C, Turk K, Duran A, Hamdan MH, Pires LA; PAVE Study Group.

J Cardiovasc Electrophysiol. 2005 Nov;16(11):1160-5.

PMID:
16302897
18.

Pulmonary-vein isolation for atrial fibrillation in patients with heart failure.

Khan MN, Jaïs P, Cummings J, Di Biase L, Sanders P, Martin DO, Kautzner J, Hao S, Themistoclakis S, Fanelli R, Potenza D, Massaro R, Wazni O, Schweikert R, Saliba W, Wang P, Al-Ahmad A, Beheiry S, Santarelli P, Starling RC, Dello Russo A, Pelargonio G, Brachmann J, Schibgilla V, Bonso A, Casella M, Raviele A, Haïssaguerre M, Natale A; PABA-CHF Investigators.

N Engl J Med. 2008 Oct 23;359(17):1778-85. doi: 10.1056/NEJMoa0708234.

19.

Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.

Saxon LA, Greenfield RA, Crandall BG, Nydegger CC, Orlov M, VAN Genderen R.

J Cardiovasc Electrophysiol. 2006 May;17(5):520-5.

PMID:
16684026
20.

Long-term outcome of the atrioventricular node ablation and pacemaker implantation for symptomatic refractory atrial fibrillation.

Tan ES, Rienstra M, Wiesfeld AC, Schoonderwoerd BA, Hobbel HH, Van Gelder IC.

Europace. 2008 Apr;10(4):412-8. doi: 10.1093/europace/eun020. Epub 2008 Feb 12.

PMID:
18272509

Supplemental Content

Support Center